Persistent Pulmonary Hypertension

PPHN: Definition & Basics - Blue Baby Blues

• Definition: Failure of postnatal circulatory transition; ↑ Pulmonary Vascular Resistance (PVR).
• Pathophysiology: Persistent fetal circulation (Right→Left shunt via PDA/PFO) → severe hypoxemia.
• Types:
  • Maladaptation (e.g., MAS, RDS)
  • Maldevelopment/Underdevelopment (e.g., CDH, pulmonary hypoplasia)
  • Idiopathic

⭐ PPHN is characterized by persistence of fetal circulatory pathways (right-to-left shunting via PDA/PFO) leading to severe hypoxemia. showing persistent fetal shunts (PDA, PFO) and right-to-left blood flow)

PPHN: Pathophysiology - Vicious Vasoconstriction

• Core Mechanisms:
  • Maladaptation: Failure of postnatal ↓ Pulmonary Vascular Resistance (PVR).
  • Maldevelopment: Abnormal pulmonary arteriolar muscularization.
  • Underdevelopment: Pulmonary hypoplasia (e.g., congenital diaphragmatic hernia).
• Key Mediator Imbalance:
  • ↓ Nitric Oxide (NO) (vasodilator).
  • ↑ Endothelin-1 (ET-1) (vasoconstrictor).
  • Prostaglandins: ↓ $PGI_2$, $PGE_2$ (vasodilators); ↑ $TXA_2$ (vasoconstrictor).

⭐ Maladaptation (failure of normal postnatal drop in PVR), often due to lung parenchymal disease (e.g., MAS, RDS) or asphyxia, is the most common underlying mechanism.

PPHN: Etiology & Risks - Trouble Triggers

PPHN results from failed circulatory transition. Key triggers include:

• Maternal Factors:
  • Diabetes Mellitus
  • NSAID use
  • SSRI use (late pregnancy)
• Neonatal Factors:
  • Meconium Aspiration Syndrome (MAS)
  • Respiratory Distress Syndrome (RDS)
  • Sepsis
  • Perinatal Asphyxia
  • Congenital Diaphragmatic Hernia (CDH)

⭐ Maternal SSRI use in late pregnancy is a significant risk factor for PPHN.

PPHN: Clinical Features - Gasping & Grim

• Respiratory Distress: Tachypnea, gasping, grunting.
• Cyanosis: Severe, labile hypoxemia.
• Differential Cyanosis:
  • Pre-ductal SpO2 > Post-ductal SpO2 by >10%.
  • Or PaO2 difference >20 mmHg.

  ⭐ Pre-ductal vs. post-ductal SpO2 difference >10% (or PaO2 >20 mmHg) is a classic sign of PPHN indicating ductal shunting.

• RV Failure Signs: Hepatomegaly.
• Auscultation: Loud, single S2; harsh systolic murmur.

PPHN: Diagnosis - Echoing Evidence

• Initial Clues:
  • CXR: Often normal or shows ↓ pulmonary vascularity.
  • ABG: Hypoxemia (PaO₂ ↓), often with hypercapnia.
  • Hyperoxia Test: PaO₂ fails to rise significantly (e.g., < 20 mmHg increase or remains < 100 mmHg) with 100% O₂.
• Gold Standard:

  ⭐ Echocardiography is the gold standard for PPHN diagnosis, directly visualizing shunts and estimating pulmonary artery pressure.

  • Shows R→L shunt (PFO/PDA), ↑ PA pressure, RV dysfunction.
• Severity:
  • Oxygenation Index (OI): $\frac{MAP \times FiO_2 \times 100}{PaO_2}$
  • OI > 25 indicates severe PPHN.

PPHN: Management - Breathing Better

• Priorities: Supportive care, target O2 (pre-ductal SpO2 90-95%), gentle ventilation (HFOV if needed).
• Key Interventions:

⭐ Inhaled Nitric Oxide (iNO) is a selective pulmonary vasodilator that improves oxygenation and reduces the need for ECMO.

High‑Yield Points - ⚡ Biggest Takeaways

• PPHN involves failure of normal circulatory transition at birth, leading to persistently high pulmonary vascular resistance (PVR).
• Results in right-to-left shunting of deoxygenated blood via the foramen ovale and ductus arteriosus.
• Presents with marked cyanosis (often refractory to 100% oxygen), tachypnea, and respiratory distress.
• A pre-ductal vs. post-ductal SpO2 difference >10% is a classic diagnostic indicator.
• Echocardiography is the gold standard for diagnosis, confirming elevated pulmonary artery pressures and shunting.
• Management includes supportive care (oxygen, ventilation), inhaled Nitric Oxide (iNO), and ECMO for severe, refractory cases.
• Often associated with meconium aspiration syndrome (MAS), asphyxia, or sepsis.